BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Spadi R, Brusa F, Ponzetti A, Chiappino I, Birocco N, Ciuffreda L, Satolli MA. Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. World J Clin Oncol 2016; 7(1): 27-43 [PMID: 26862489 DOI: 10.5306/wjco.v7.i1.27]
URL: https://www.wjgnet.com/2218-4333/full/v7/i1/27.htm
Number Citing Articles
1
Chunhui Nie, Yuelin Zhang, Guanhui Zhou, Tanyang Zhou, Tongyin Zhu, Baoquan Wang, Shengqun Chen, Hongliang Wang, Ziniu Yu, Li Jing, Junhui Sun. Analysis of the efficacy of transcatheter arterial infusion chemotherapy in the treatment of pancreatic carcinomaJournal of Interventional Medicine 2021; 4(1): 21 doi: 10.1016/j.jimed.2020.10.005
2
Jaeyun Jung, Cue Hyunkyu Lee, Hyang Sook Seol, Yeon Sook Choi, Eunji Kim, Eun Ji Lee, Je-Keun Rhee, Shree Ram Singh, Eun Sung Jun, Buhm Han, Seung Mo Hong, Song Cheol Kim, Suhwan Chang. Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous natureOncotarget 2016; 7(38): 62533 doi: 10.18632/oncotarget.11530
3
Zensho Ito, Shin Kan, Tsuuse Bito, Sankichi Horiuchi, Takafumi Akasu, Sayumi Yoshida, Mikio Kajihara, Atsushi Hokari, Masayuki Saruta, Noriyuki Yoshida, Masanori Kobayashi, Toshifumi Ohkusa, Shigetaka Shimodaira, Masato Okamoto, Haruo Sugiyama, Shigeo Koido. Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1Oncology 2019; 97(3): 135 doi: 10.1159/000500359
4
Ugo Soffientini, Annette Graham. Intracellular cholesterol transport proteins: roles in health and diseaseClinical Science 2016; 130(21): 1843 doi: 10.1042/CS20160339
5
Fan Lei, Xinyuan Xi, Surinder K. Batra, Tatiana K. Bronich. Combination Therapies and Drug Delivery Platforms in Combating Pancreatic CancerJournal of Pharmacology and Experimental Therapeutics 2019; 370(3): 682 doi: 10.1124/jpet.118.255786
6
Aesha I. Ali, Amanda J. Oliver, Tinaz Samiei, Jack D. Chan, Michael H. Kershaw, Clare Y. Slaney. Genetic Redirection of T Cells for the Treatment of Pancreatic CancerFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00056
7
Sriram Anbil, Michael Pigula, Huang-Chiao Huang, Srivalleesha Mallidi, Mans Broekgaarden, Yan Baglo, Pushpamali De Silva, Diane M. Simeone, Mari Mino-Kenudson, Edward V. Maytin, Imran Rizvi, Tayyaba Hasan. Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose ChemotherapyMolecular Cancer Therapeutics 2020; 19(6): 1308 doi: 10.1158/1535-7163.MCT-19-0791
8
Zhennan Yun, Fanqi Meng, Shiquan Li, Ping Zhang. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axisAging 2021; 13(4): 6041 doi: 10.18632/aging.202540
9
Serena Veschi, Laura De Lellis, Rosalba Florio, Paola Lanuti, Alberto Massucci, Nicola Tinari, Michele De Tursi, Pierluigi di Sebastiano, Marco Marchisio, Clara Natoli, Alessandro Cama. Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cellsJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0904-2
10
Fang Xie, Mei Huang, Xiansheng Lin, Chenhai Liu, Zhen Liu, Futao Meng, Chao Wang, Qiang Huang. RETRACTED ARTICLE: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabineScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-26496-0
11
Susanna Hegewisch‐Becker, Ali Aldaoud, Thomas Wolf, Beate Krammer‐Steiner, Hartmut Linde, Renate Scheiner‐Sparna, David Hamm, Martina Jänicke, Norbert Marschner. Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinomaInternational Journal of Cancer 2019; 144(5): 981 doi: 10.1002/ijc.31751
12
Amir Hossein Daneshmanesh, Mohammad Hojjat-Farsangi, Amineh Ghaderi, Ali Moshfegh, Lotta Hansson, Johan Schultz, Jan Vågberg, Styrbjörn Byström, Elisabeth Olsson, Thomas Olin, Anders Österborg, Håkan Mellstedt, Aamir Ahmad. A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinibPLOS ONE 2018; 13(6): e0198038 doi: 10.1371/journal.pone.0198038
13
Louisa Stern, Lukas Boehme, Mara Goetz, Christine Nitschke, Anastasios Giannou, Tao Zhang, Cenap Güngör, Matthias Reeh, Jakob Izbicki, Ralf Fliegert, Anne Hausen, Nathalia Giese, Thilo Hackert, Masha Niv, Stefan Heinrich, Matthias Gaida, Tarik Ghadban. Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigeninInternational Journal of Oncology 2022; 62(1) doi: 10.3892/ijo.2022.5454
14
Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, Kaio Murilo Monteiro Espíndola, Amanda Caroline R. S. Rosario, Wenddy Graziela N. Lima, Marta Chagas Monteiro. Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.594917
15
Gertrud Forika, Andrea Balogh, Tamas Vancsik, Attila Zalatnai, Gabor Petovari, Zoltan Benyo, Tibor Krenacs. Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In VitroInternational Journal of Molecular Sciences 2020; 21(14): 5100 doi: 10.3390/ijms21145100
16
P. G. Tarazov, A. V. Kozlov, D. A. Granov, A. V. Pavlovskiy, A. A. Polikarpov, E. V. Rozengaus, S. A. Popov, E. V. Vlasova, V. E. Moiseenko. ARTERIAL CHEMOINFUSION IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC PANCREAS CANCERGrekov's Bulletin of Surgery 2016; 175(5): 36 doi: 10.24884/0042-4625-2016-175-5-36-40
17
Feifan Zhou, Jingxuan Yang, Yuqing Zhang, Mingyang Liu, Mark L. Lang, Min Li, Wei R. Chen. Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor VaccineClinical Cancer Research 2018; 24(21): 5335 doi: 10.1158/1078-0432.CCR-18-1126
18
Randy Yeh, Jonathan Steinman, Lyndon Luk, Michael D. Kluger, Elizabeth M. Hecht. Imaging of pancreatic cancer: what the surgeon wants to knowClinical Imaging 2017; 42: 203 doi: 10.1016/j.clinimag.2016.10.002
19
Ching-Yao Yang, Ming Huei Fan, Carol H. Miao, Yi Jen Liao, Ray-Hwang Yuan, Chao Lien Liu. Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic CancerMolecular Therapy - Oncolytics 2020; 17: 571 doi: 10.1016/j.omto.2020.05.009
20
Ganji Purnachandra Nagaraju, Katerina M. Zakka, Jerome C. Landry, Walid L. Shaib, Gregory B. Lesinski, Bassel F. El‐Rayes. Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancerInternational Journal of Cancer 2019; 145(6): 1529 doi: 10.1002/ijc.32227
21
Derek K. Cheng, Tobiloba E. Oni, Jennifer S. Thalappillil, Youngkyu Park, Hsiu-Chi Ting, Brinda Alagesan, Nadia V. Prasad, Kenneth Addison, Keith D. Rivera, Darryl J. Pappin, Linda Van Aelst, David A. Tuveson. Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancerProceedings of the National Academy of Sciences 2021; 118(21) doi: 10.1073/pnas.2016904118
22
Hongchao Han, Lisheng Wang, Jie Xu, Aikun Wang. miR‑128 induces pancreas cancer cell apoptosis by targeting MDM4Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6047
23
Negin Rahnama, Mohammadsaleh Jahangir, Samira Alesaeid, Mohammad Saeed kahrizi, Ali Adili, Rebar N. Mohammed, Ramin Aslaminabad, Morteza Akbari, Ali Mert Özgönül. Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectivesPathology - Research and Practice 2022; 236: 153982 doi: 10.1016/j.prp.2022.153982
24
Avital Lev, Amriti R. Lulla, Jessica Wagner, Marie D. Ralff, Joshua B. Kiehl, Yan Zhou, Cyril H. Benes, Varun V. Prabhu, Wolfgang Oster, Igor Astsaturov, David T. Dicker, Wafik S. El-Deiry. Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIPOncotarget 2017; 8(47): 81776 doi: 10.18632/oncotarget.20819
25
Sarah J. Hartman, Stacey M. Bagby, Betelehem W. Yacob, Dennis M. Simmons, Morgan MacBeth, Christopher H. Lieu, S. Lindsey Davis, Alexis D. Leal, John J. Tentler, Jennifer R. Diamond, S. Gail Eckhardt, Wells A. Messersmith, Todd M. Pitts. WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal AdenocarcinomaFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.642328
26
Serena Veschi, Maurizio Ronci, Paola Lanuti, Laura De Lellis, Rosalba Florio, Giuseppina Bologna, Luca Scotti, Erminia Carletti, Federica Brugnoli, Maria Cristina Di Bella, Valeria Bertagnolo, Marco Marchisio, Alessandro Cama. Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cellsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59492-4
27
Bo Chen, Tuo Deng, Liming Deng, Haitao Yu, Bangjie He, Kaiyu Chen, Chongming Zheng, Daojie Wang, Yi Wang, Gang Chen. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinomaBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08962-7
28
Chundong Cheng, Zonglin Liu, Danxi Liu, Hua Chen, Yongwei Wang, Bei Sun. LncRNA CCAT1 participates in pancreatic ductal adenocarcinoma progression by forming a positive feedback loop with c-MycCarcinogenesis 2024; 45(1-2): 69 doi: 10.1093/carcin/bgad076
29
Merin Joseph, Muhammed Shafeeque Rahman Pathiripparambath, Hanas Tharayil, Ramapurath S. Jayasree, Lakshmi V. Nair. Copper Nanocluster Enables Simultaneous Photodynamic and Chemo Therapy for Effective Cancer Diagnosis and Treatment in VitroChemMedChem 2022; 17(19) doi: 10.1002/cmdc.202200201
30
Callum Baird Nattress, Gunnel Halldén. Advances in oncolytic adenovirus therapy for pancreatic cancerCancer Letters 2018; 434: 56 doi: 10.1016/j.canlet.2018.07.006
31
Navni Sharma, Vimal Arora. Strategies for drug targeting in pancreatic cancerPancreatology 2022; 22(7): 937 doi: 10.1016/j.pan.2022.08.001
32
Rosalba Florio, Barbara De Filippis, Serena Veschi, Viviana di Giacomo, Paola Lanuti, Giulia Catitti, Davide Brocco, Annalisa di Rienzo, Amelia Cataldi, Ivana Cacciatore, Rosa Amoroso, Alessandro Cama, Laura De Lellis. Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer CellsInternational Journal of Molecular Sciences 2023; 24(3): 1977 doi: 10.3390/ijms24031977
33
Jesse M. Mast, Dan Tse, Kevin Shee, M. Lakshmi Kuppusamy, Maciej M. Kmiec, Tamás Kálai, Periannan Kuppusamy. Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer CellsCell Biochemistry and Biophysics 2019; 77(2): 109 doi: 10.1007/s12013-019-00873-6
34
Bo Yang, Yanni Quan, Wuli Zhao, Yingjie Ji, Xiaotang Yang, Jianrui Li, Yi Li, Xiujun Liu, Ying Wang, Yanping Li. Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitorsJournal of Enzyme Inhibition and Medicinal Chemistry 2023; 38(1) doi: 10.1080/14756366.2023.2169282
35
Shanshan Liu, Jiawen He, Ruixiang Song, Mengmeng Zhang, Lianghao Huang, Jing Chen, Meng Wang, Fang Liu, Feifan Zhou. Fe2P nanorods based photothermal therapy combined with immune checkpoint inhibitors for pancreatic cancerNanophotonics 2021; 10(12): 3267 doi: 10.1515/nanoph-2021-0196
36
Dimitrios Moris, Nikolaos Machairas, Diamantis I. Tsilimigras, Anastasia Prodromidou, Aslam Ejaz, Matthew Weiss, Natasha Hasemaki, Evangelos Felekouras, Timothy M. Pawlik. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic CancerAnnals of Surgical Oncology 2019; 26(6): 1657 doi: 10.1245/s10434-019-07261-7
37
Kai Xu, Yongliang Chen, Junjun Su, Ming Su, Li Yan. Irreversible electroporation and adjuvant chemoradiotherapy for locally advanced pancreatic carcinomaJournal of Cancer Research and Therapeutics 2020; 16(2): 280 doi: 10.4103/jcrt.JCRT_773_18
38
Yanyan Hu, Chongwei Chi, Shunhao Wang, Lingxiong Wang, Ping Liang, Fangyi Liu, Wenting Shang, Weiwei Wang, Fengrong Zhang, Shanshan Li, Heyun Shen, Xiaoling Yu, Huiyu Liu, Jie Tian. A Comparative Study of Clinical Intervention and Interventional Photothermal Therapy for Pancreatic CancerAdvanced Materials 2017; 29(33) doi: 10.1002/adma.201700448
39
Dong S., Wang L., Guo Y. B., Ying H. F., Shen X. H., Meng Z. Q., Chen Hao, Chen Q. W., Li Z. S.. Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort studyWorld Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1175-7
40
Shiwei Guo, Suizhi Gao, Rendong Liu, Jing Shen, Xiaohan Shi, Sijia Bai, Huan Wang, Kailian Zheng, Zhuo Shao, Chuanyu Liang, Siying Peng, Gang Jin. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancerThe FASEB Journal 2019; 33(1): 873 doi: 10.1096/fj.201800617R
41
Eun A Choi, Yeon-Sook Choi, Eun Ji Lee, Shree Ram Singh, Song Cheol Kim, Suhwan Chang. A pharmacogenomic analysis using L1000CDS2 identifies BX-795 as a potential anticancer drug for primary pancreatic ductal adenocarcinoma cellsCancer Letters 2019; 465: 82 doi: 10.1016/j.canlet.2019.08.002
42
Adriana Harbuzariu, Antonio Rampoldi, Danielle S Daley-Brown, Pierre Candelaria, Tia L Harmon, Crystal C Lipsey, Derrick J Beech, Alexander Quarshie, Gabriela Oprea Ilies, Ruben R Gonzalez-Perez. Leptin-Notch signaling axis is involved in pancreatic cancer progressionOncotarget 2017; 8(5): 7740 doi: 10.18632/oncotarget.13946
43
A. V. Kozlov, D. A. Granov, P. G. Tarazov, A. V. Pavlovskiy, L. I. Korytova, A. A. Polikarpov, S. A. Popov, E. V. Rozengauz. Intra-arterial chemotherapy for advanced pancreatic cancerAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2019; 24(3): 73 doi: 10.16931/1995-5464.2019373-86
44
John P. Neoptolemos, Jörg Kleeff, Patrick Michl, Eithne Costello, William Greenhalf, Daniel H. Palmer. Therapeutic developments in pancreatic cancer: current and future perspectivesNature Reviews Gastroenterology & Hepatology 2018; 15(6): 333 doi: 10.1038/s41575-018-0005-x
45
Diamantis I. Tsilimigras, Dimitrios Moris, Timothy M. Pawlik. ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic CancerAnnals of Surgical Oncology 2019; 26(S3): 610 doi: 10.1245/s10434-019-07436-2
46
Karin Juliane Pelizzaro Rocha-Brito, Emanuella Maria Barreto Fonseca, Breno Germano de Freitas Oliveira, Ângelo de Fátima, Carmen Veríssima Ferreira-Halder. Calix[6]arene diminishes receptor tyrosine kinase lifespan in pancreatic cancer cells and inhibits their migration and invasion efficiencyBioorganic Chemistry 2020; 100: 103881 doi: 10.1016/j.bioorg.2020.103881
47
Shui-Fang Jin, Zhao-Kun Fan, Lei Pan, Li-Ming Jin. Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trialsHepatobiliary & Pancreatic Diseases International 2017; 16(3): 236 doi: 10.1016/S1499-3872(17)60022-5
48
Zhe Pei, Wei Fu, Gongping Wang. A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signalingBiochemical and Biophysical Research Communications 2017; 493(1): 455 doi: 10.1016/j.bbrc.2017.08.170
49
Ghaidaa Raheem Lateef Al-Awsi, Saade Abdalkareem Jasim, Yasser Fakri Mustafa, Firas Rahi Alhachami, Shukhrat Ziyadullaev, Mahmoud Kandeel, Roua Abulkassim, R Sivaraman, Noora M Hameed, Rosario Mireya Romero Parra, Sajad Karampoor, Rasoul Mirzaei. The role of miRNA-128 in the development and progression of gastrointestinal and urogenital cancerFuture Oncology 2022; 18(38): 4209 doi: 10.2217/fon-2022-0574
50
Qijun Yi, Jie Wang, Tingting Liu, Yi Yao, Ian Loveless, Kalpana Subedi, Jugmohit Toor, Indra Adrianto, Hua Xiao, Bin Chen, Howard C. Crawford, Deyu Fang, Li Zhou, Qing-Sheng Mi. scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasisCancer Letters 2023; 561: 216149 doi: 10.1016/j.canlet.2023.216149
51
Metin Uz, Manisha Kalaga, Ramesh Pothuraju, Juhyung Ju, Wade M. Junker, Surinder K. Batra, Surya Mallapragada, Satyanarayana Rachagani. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancerJournal of Controlled Release 2019; 294: 237 doi: 10.1016/j.jconrel.2018.12.031
52
Jiachun Ding, Jiaqiang Ren, Fan Chen, Yangyang Yue, Chao Ren, Xirui Wang, Qingyong Ma, Zheng Wu, Zheng Wang. Prognostic Nomogram for pancreatic cancer with lung metastasis: a SEER database-based studyJournal of Pancreatology 2021; 4(1): 28 doi: 10.1097/JP9.0000000000000059
53
Arndt Vogel, Fortunato Ciardiello, Richard A. Hubner, Jean-Frédéric Blanc, Alfredo Carrato, Yoojung Yang, Dipen A. Patel, Varun Ektare, Floris A. de Jong, Sharlene Gill. Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimensCancer Treatment Reviews 2016; 50: 142 doi: 10.1016/j.ctrv.2016.09.001
54
Yunpeng Sun, Qiandong Zhu, Mengtao Zhou, Wenjun Yang, Hongqi Shi, Yunfeng Shan, Qiyu Zhang, Fuxiang Yu. Restoration of miRNA‑148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β‑catenin signaling pathway via downregulating maternally expressed gene‑3Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.7026
55
Claire Vennin, Nicola Rath, Marina Pajic, Michael F. Olson, Paul Timpson. Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapySmall GTPases 2020; 11(1): 45 doi: 10.1080/21541248.2017.1345712
56
Kai Qu, Xing Zhang, Ting Lin, Tian Liu, Zhixin Wang, Sushun Liu, Lei Zhou, Jichao Wei, Hulin Chang, Ke Li, Zheng Wang, Chang Liu, Zheng Wu. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validationScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01904-z
57
Sayumi Yoshida, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Takafumi Akasu, Masayuki Saruta, Masato Okamoto, Hiroaki Kitamura, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Haruo Sugiyama, Shigeo Koido. Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic CancerCancer Investigation 2019; 37(9): 463 doi: 10.1080/07357907.2019.1661427
58
Xiaolong Wei, Jiekun Yang, Sara J. Adair, Harun Ozturk, Cem Kuscu, Kyung Yong Lee, William J. Kane, Patrick E. O’Hara, Denis Liu, Yusuf Mert Demirlenk, Alaa Hamdi Habieb, Ebru Yilmaz, Anindya Dutta, Todd W. Bauer, Mazhar Adli. Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cellsProceedings of the National Academy of Sciences 2020; 117(45): 28068 doi: 10.1073/pnas.2009899117